Amyloid Protein-Biofunctionalized Polydopamine Nanoparticles Demonstrate Minimal Plasma Protein Fouling and Efficient Photothermal Therapy-Reference-Cited by-同舟云学术

Amyloid Protein-Biofunctionalized Polydopamine Nanoparticles Demonstrate Minimal Plasma Protein Fouling and Efficient Photothermal Therapy

Published:2022-03-10 Issue:11 Volume:14 Page:13743-13757
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Han Miaomiao¹,Li Yan¹,Lu Shun¹,Yuan Biao¹,Cheng Shujie¹^ORCID,Cao Chongjiang¹^ORCID

Affiliation:

1. Department of Food Quality and Safety/National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical University, Nanjing 211198, China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.2c00716

Reference68 articles.

1. Nanomedicine-Challenge and Perspectives

2. Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials

3. 2D Black Phosphorus–Based Biomedical Applications

4. Biodegradation of Iron Oxide Nanocubes: High-Resolution In Situ Monitoring

5. Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H2O2 self-supplying Ce6@ZIF-8/PDA/CuO2/HA (CZPCH) nanoplatform for enhanced reactive oxygen species (ROS)-mediated tumor therapy;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-09

2. Polydopamine Applications in Biomedicine and Environmental Science;Materials;2024-08-07

3. PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair;Drug Delivery and Translational Research;2024-07-02

4. Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood–Brain Barrier;Cells;2024-05-07

5. Research progress of organic photothermal agents delivery and synergistic therapy systems;Colloids and Surfaces B: Biointerfaces;2024-02